Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.599.298.476.144.89

What is the latest EV/Core EBITDA ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of AAREY DRUGS & PHARMACEUTICALS is 13.59 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.59
Mar20239.29
Mar20228.47
Mar20216.14
Mar20204.89

How is EV/Core EBITDA of AAREY DRUGS & PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.59
46.29
Mar2023 9.29
9.68
Mar2022 8.47
37.95
Mar2021 6.14
25.56
Mar2020 4.89 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹137.5 Cr 7.2% -14.6% -10.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr 2.2% -5.8% 22.9% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 4.1% -7% 52% Stock Analytics
CIPLA ₹116,123.0 Cr 1.3% -4.8% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 2.2% -10.9% -0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 7% -0.2% 27.5% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

7.2%

-14.6%

-10.4%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses